Safety, Tolerability, and Pharmacodynamics of ABT-122, a TNF- And IL-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With RA
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40319
Full Text
Open PDFAbstract
Available in full text
Date
November 8, 2017
Authors
Publisher
Wiley